Brief: Scope Fluidics Updates On Further Steps For PCR|One and BacterOMIC Projects

Scope Fluidics SA

27/09/2021 09:57

Sept 27 (Reuters) - Scope Fluidics SA  SCPP.WA :
    * SAID ON FRIDAY MANAGEMENT RESOLVES ON FURTHER STEPS FOR
PCR|ONE
AND BACTEROMIC PROJECTS
    * GROUP'S MAIN OPERATING GOAL FOR PCR|ONE SYSTEM IS SALE OF
STAKE
IN CURIOSITY DIAGNOSTICS, RESPONSIBLE FOR DEVELOPING SYSTEM
    * PLAN FOR CURIOSITY DIAGNOSTICS WITH ONE-YEAR SCOPE
INCLUDES
PREPARING IT OPERATIONALLY TO MARKET PCR|ONE SYSTEM
INDEPENDENTLY
    * COMPANY IS CURRENTLY IN TALKS WITH SELECTED GLOBAL MEDICAL
DIAGNOSTIC ENTITIES REGARDING PCR|ONE FUNCTIONALITY, TEST
PORTFOLIO DEVELOPMENT PLANS, SALE DEVELOPMENT PLANS, COMPONENT
SUPPLY CHAIN, PRODUCTION CAPACITY, COSTS AND SCALABILITY
    * ALSO SAID MAIN GOAL FOR BACTEROMIC PROJECT IS ITS
COMMERCIALISATION THROUGH SALE OF STAKE IN BACTEROMIC SP. Z O.O.
    * PLAN FOR BACTEROMIC WITH ONE-YEAR SCOPE IS AIMED AT
BUILDING
MARKET POSITION AND RECOGNISABILITY OF BACTEROMIC SYSTEM AND
PREPARING UNIT BACTEROMIC TO SCALE PRODUCTION
    * MANAGEMENT INTENDS TO FINANCE PLANS VIA SUITABLE
IMPLEMENTATION
OF SEPTEMBER 2020 FINANCING DEAL WITH EUROPEAN INVESTMENT BANK,
GRANTS AND OWN FUNDS
    * MANAGEMENT DOES NOT EXCLUDE POSSIBILITY OF SEEKING OTHER
SOURCES
OF FINANCING
    * MANGEMENT WILL ACT TOWARDS ENABLING COMPANY TO USE ALL
TRANCHES
OF FINANCING FROM EUROPEAN INVESTMENT BANK
    * MANAGEMENT INTENDS TO USE FIRST TRANCHE OF EUROPEAN
INVESTMENT
BANK FINANCING IN Q4 2021 AND IS CONSIDERING USING SECOND
TRANCHE IN H1 2022

    
 
    
 Source text for Eikon:  urn:newsml:reuters.com:*:nEM7JfKT5a
 Further company coverage:  SCPP.WA  

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))